These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36994214)

  • 41. An experimental study to evaluate the Fluobeam 800 imaging system for fluorescence-guided lymphatic imaging and sentinel node biopsy.
    Hirche C; Engel H; Kolios L; Cognie J; Hünerbein M; Lehnhardt M; Kremer T
    Surg Innov; 2013 Oct; 20(5):516-23. PubMed ID: 23275469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison between laparoscopic and robotic surgery for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging.
    Chaowawanit W; Campbell V; Wilson E; Chetty N; Perrin L; Jagasia N; Barry S
    J Obstet Gynaecol; 2021 May; 41(4):642-646. PubMed ID: 32812452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
    Tsao MW; Cornacchi SD; Hodgson N; Simunovic M; Thabane L; Cheng J; O'Brien MA; Strang B; Mukherjee SD; Lovrics PJ
    Ann Surg Oncol; 2016 Oct; 23(10):3354-64. PubMed ID: 27342830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
    Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A
    Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer.
    Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS
    World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study.
    Chéreau E; Uzan C; Boutmy-Deslandes E; Zohar S; Bézu C; Mazouni C; Garbay JR; Daraï E; Rouzier R
    PLoS One; 2016; 11(6):e0156096. PubMed ID: 27280398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgeon Bias in the Management of Positive Sentinel Lymph Nodes.
    Mathias BJ; Sun J; Sun W; Zhou JM; Fulp WJ; Laronga C; Lee MC; Kiluk JV
    Clin Breast Cancer; 2021 Feb; 21(1):74-79. PubMed ID: 32917535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.
    Tokmak H; Kaban K; Muslumanoglu M; Demirel M; Aktan S
    World J Surg Oncol; 2014 Jul; 12():205. PubMed ID: 25016393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011.
    Olson JA; McCall LM; Beitsch P; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
    J Clin Oncol; 2008 Jul; 26(21):3530-5. PubMed ID: 18640934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study.
    Coufal O; Fait V
    World J Surg Oncol; 2016 Dec; 14(1):299. PubMed ID: 27905950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients.
    van der Vorst JR; Schaafsma BE; Verbeek FP; Keereweer S; Jansen JC; van der Velden LA; Langeveld AP; Hutteman M; Löwik CW; van de Velde CJ; Frangioni JV; Vahrmeijer AL
    Oral Oncol; 2013 Jan; 49(1):15-9. PubMed ID: 22939692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new indocyanine green fluorescence lymphography protocol for identification of the lymphatic drainage pathway for patients with breast cancer-related lymphoedema.
    Suami H; Heydon-White A; Mackie H; Czerniec S; Koelmeyer L; Boyages J
    BMC Cancer; 2019 Oct; 19(1):985. PubMed ID: 31640623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The influence of lumpectomy on the axillary lymph node status of breast cancer patients].
    Jiao DC; Zhu JJ; Qiao JH; Wang LN; Ma YZ; Lu ZD; Liu ZZ
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):284-287. PubMed ID: 29730916
    [No Abstract]   [Full Text] [Related]  

  • 55. Fluorescent Lymphography-Guided Lymphadenectomy During Robotic Radical Gastrectomy for Gastric Cancer.
    Kwon IG; Son T; Kim HI; Hyung WJ
    JAMA Surg; 2019 Feb; 154(2):150-158. PubMed ID: 30427990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Clinical Value of Fluorescent Lymphography with Indocyanine Green During Robotic Surgery for Gastric Cancer: a Matched Cohort Study.
    Cianchi F; Indennitate G; Paoli B; Ortolani M; Lami G; Manetti N; Tarantino O; Messeri S; Foppa C; Badii B; Novelli L; Skalamera I; Nelli T; Coratti F; Perigli G; Staderini F
    J Gastrointest Surg; 2020 Oct; 24(10):2197-2203. PubMed ID: 31485904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indocyanine green fluorescence lymphography during gastrectomy after initial endoscopic submucosal dissection for early gastric cancer.
    Roh CK; Choi S; Seo WJ; Cho M; Son T; Kim HI; Hyung WJ
    Br J Surg; 2020 May; 107(6):712-719. PubMed ID: 32031248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.
    Cox C; White L; Allred N; Meyers M; Dickson D; Dupont E; Cantor A; Ly Q; Dessureault S; King J; Nicosia S; Vrcel V; Diaz N
    Ann Surg Oncol; 2006 May; 13(5):708-11. PubMed ID: 16538416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients.
    van der Vorst JR; Schaafsma BE; Verbeek FP; Hutteman M; Mieog JS; Lowik CW; Liefers GJ; Frangioni JV; van de Velde CJ; Vahrmeijer AL
    Ann Surg Oncol; 2012 Dec; 19(13):4104-11. PubMed ID: 22752379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of survival outcomes between axillary conservation and axillary lymph node dissections in N1 early breast cancer: a propensity-matched SEER analysis.
    Wu N; Su X; Tan Q; Luo J; Yuan Y; Hou L; Li J
    Clin Transl Oncol; 2023 Apr; 25(4):1091-1101. PubMed ID: 36515887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.